Konstantinos Gkagkalidis

Konstantinos Gkagkalidis

Auto-generated profile, based on publicly available information

Konstantinos Gkagkalidis

1st Department of Urology, Gennimatas General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
CTChrysovalantis Toutziaris
Chrysovalantis Toutziaris
SKSpyridon Kampantais
Spyridon Kampantais
IPIoannis Perdikis
Ioannis Perdikis
VGVictoras Gourvas
Victoras Gourvas
LLLeonidas Laskaridis
Leonidas Laskaridis
SIStavros Ioannidis
Stavros Ioannidis
INTRODUCTION: The presence of a mass in the epididymis is not a common entity. The papillary cystadenoma of epididymis is a benign tumor which may occur sporadically or as a characteristic of von Hippel-Lindau disease. PRESENTATION OF CASE: We present a case of a 27-year-old man with a right scrotal mass who was treated with surgical excision. Histopathological examination revealed a clear cell epididymal papillary cystadenoma. A computed tomography scan that was performed later showed no other abnormality or any signs of von Hippel-Lindau disease. DISCUSSION: In this report, a case of a young man suffering from this rare tumor is discussed, focusing on the need of further evaluation in order to determinate if it occurs as a feature of VHL disease or as a sporadic form. CONCLUSION: In unilateral cases of papillary cystadenoma of epididymis such as our patient's, literature advocates that no further examinations and expensive genetic testing is required.

1 October 2013 in European Urology Supplements
Verified
Journal Article
Closed access
LLL. Laskaridis
L. Laskaridis
SKS. Kampantais
S. Kampantais
FSF. Sardaridis
F. Sardaridis
DTD. Tsolakis
D. Tsolakis
AKA. Koudonas
A. Koudonas
SIS. Ioannidis
S. Ioannidis

1 October 2013 in European Urology Supplements
Verified
Journal Article
Closed access
KGK. Gkagkalidis
K. Gkagkalidis
MKM. Koptsis
M. Koptsis
SKS. Kampantais
S. Kampantais
LLL. Laskaridis
L. Laskaridis
DPD. Pavlakis
D. Pavlakis
CTChrysovalantis Toutziaris
Chrysovalantis Toutziaris

29 October 2020 in The International Journal of Biological Markers
Verified
Journal Article
Open access
PDF file
SKSpyridon Kampantais
Spyridon Kampantais
IKIlias Kounatidis
Ilias Kounatidis
VKVasiliki Kotoula
Vasiliki Kotoula
IVIoannis Vakalopoulos
Ioannis Vakalopoulos
KGKonstantinos Gkagkalidis
Konstantinos Gkagkalidis
GDGeorgios Dimitriadis
Georgios Dimitriadis
Hypoxia inducible factors (HIF) and prolyl hydroxylase domain (PHD) enzymes play a central role in tumor progression in clear cell renal cell carcinoma (ccRCC). However, there are currently no data regarding the behavior of this pathway (HIF/PHD) in a large number of benign renal tumors, the oncocytomas. The aim of the present study was to compare the expression levels of these factors between ccRCC and oncocytoma tumors. A total of 56 fresh frozen specimens from patients with ccRCC and 14 oncocytoma specimens were analyzed via reverse transcription-quantitative polymerase chain reaction in order to assess the expression levels of HIF-1α, HIF-2α, PHD1, PHD2, and PHD3. The analysis involved both fresh frozen tumor samples as well as adjacent normal kidney tissues. In ccRCC, HIF-1α and HIF-2α levels were upregulated in 65.5% and 71.4% of cases, respectively. PHD3 was downregulated only in 15.4% of the ccRCC cases, in contrast with oncocytoma cases, which exhibited low expression levels in the majority. The upregulation of PHD3 messenger RNA (mRNA) levels in ccRCC when compared with oncocytoma was statistically significant (P<0.001). No other comparisons (HIF-1α, HIF-2α, PHD1, and PHD2) were significantly different. HIF-2α and PHD3 mRNA expression levels were negatively correlated with Fuhrman Grade (P=0.029 and P=0.026, respectively) in ccRCC. To the best of our knowledge, this is the first time that the HIF/PHD pathway was compared between ccRCC and a common benign tumor, identifying the upregulation of PHD3 as the possible underlying factor guiding the difference in the behavior of ccRCC.